Ally Bridge Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Ally Bridge Group’s Portfolio CERE Stock Details CERE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$4.5M	Hold
2022 Q1	$5.95M	Buy
2021 Q3	–	Sell
2021 Q2	$17.3M	Sell
2021 Q1	$23.7M	Sell
2020 Q4	$29.3M	Buy